Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-01-16
1994-08-30
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546321, C07D21186, A61K 31455
Patent
active
053428471
ABSTRACT:
The invention relates to the new dimethyl 2,6-dimethyl-1-n-propyl-4-(trifluoro-methylphenyl)-1,4-dihydropyridine-3-d icarboxylate, a process for its preparation and its use as a medicament in ischaemic diseases which are associated with disorders of the microcirculation. This action can occur both in the peripheral and in the cerebral vascular system.
REFERENCES:
patent: 3883543 (1975-05-01), Bossert
patent: 3956341 (1976-05-01), Loev
patent: 4707486 (1987-11-01), Flockerzi et al.
patent: 4780538 (1988-10-01), Pitzenberger et al.
patent: 4975440 (1990-12-01), Flockerzi et al.
H. Dornow and W. Sassenberg, Liebigs Ann. Chem. 602, 14 (1957) Beilstein 7 (3), 1013.
Behner Otto
Goldmann Siegfried
Rosen Bruno
Wollweber Hartmund
Zaiss Siegfried
Bayer Aktiengesellschaft
Fan Jane T.
LandOfFree
Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester and its does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester and its, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific 1,4-dihydropyridine-3,5-dicarboxylic acid ester and its will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-30176